Sindod, Bb Boy .
HRN: 23-59-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/31/2023
09/06/2023
IV
34mg
OD
Possible Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes